| Teva Pharma AG - Fluorouracil-Teva, Injektions-/Infusionslösung |
| 47160 | | 01 | | Fluorouracil-Teva | | Injektions-/Infusionslösung | | L01BC02 | | Fluorouracil | | 31.01.1986 | | |
|
| Composition |
| fluorouracilum 50 mg, natrii hydroxidum corresp. natrium 8.22 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Infusion solution | | | | | | | | Active Agent | Dose |
|---|
| Fluorouracil | 50 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Fluorouracil | 5000 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 154 | Durchstechflasche(n) à 250 mg | 3.00 | 12.50 | A | SL | Yes | | 162 | Durchstechflasche(n) à 500 mg | 4.38 | 14.00 | A | SL | Yes | | 170 | Durchstechflasche(n) à 1000 mg | 6.80 | 16.60 | A | SL | Yes | | 171 | Durchstechflasche(n) à 5000 mg | 27.18 | 45.95 | A | SL | Yes |
|
